Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.

Annals of internal medicine - 16 Feb 2010

Levine Stewart J, Wenzel Sally E

Abstract excerpt

New therapeutic approaches are needed for patients with severe asthma who are refractory to standard therapy comprising high doses of inhaled corticosteroids plus long-acting beta(2)-agonists. Current treatment guidelines for patients with severe asthma from the National Asthma Education and Prevention Program recommend the addition of oral corticosteroids, which are associated with substantial morbidity, and,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Asthmatic Agents
Share to Asthma
Share to Clinical Protocols

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunologic Factors

Share to Phenotype

Share to Th2 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 20157138
DOI: 10.7326/0003-4819-152-4-201002160-00008
PMCID: PMC2846792

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.PMID 20157138Read ↗

Biologic Therapy and Novel Molecular Targets of Severe Asthma.Semantic proximity Read ↗

Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic FrontiersSemantic proximity Read ↗

Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.Semantic proximity Read ↗

Characteristics, phenotypes, mechanisms and management of severe asthma.Semantic proximity Read ↗

Which biomarkers are effective for identifying Th2-driven inflammation in asthma?Semantic proximity Read ↗

Immunobiology of the critical asthma syndrome.Semantic proximity Read ↗

Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.Semantic proximity Read ↗

Applying personalized medicine to adult severe asthma.Semantic proximity Read ↗

Pharmacological Therapy of Bronchial Asthma: The Role of Biologicals.Semantic proximity Read ↗

Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.Semantic proximity Read ↗

Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted ApproachSemantic proximity Read ↗

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.